Genetics and cardiac anomalies : The heart of the matter

Indian Journal of Pediatrics

Volumn 69, Issue 4, 2002, Pages 321-332

  Prasad, Chitra ^a,b   Chudley, Albert E ^a  

^a CHILDREN S HOSPITAL RESEARCH INSTITUTE OF MANITOBA   (Canada)

^b NONE   (Canada)

Author keywords

22q11 deletion; Cardiac anomalies; Down syndrome; Extra cardiac anomalies; Facial dysmorphism

Indexed keywords

CHROMOSOME 21; CHROMOSOME 22; CHROMOSOME DELETION; CONGENITAL HEART MALFORMATION; DOWN SYNDROME; FLUORESCENCE IN SITU HYBRIDIZATION; GENETICS; HUMAN; PEDIATRICS; PHENOTYPE; REVIEW; WILLIAMS BEUREN SYNDROME;

CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 21; CHROMOSOMES, HUMAN, PAIR 22; DOWN SYNDROME; HEART DEFECTS, CONGENITAL; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; PEDIATRICS; PHENOTYPE; WILLIAMS SYNDROME;

EID: 0036550531     PISSN: 00195456     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02723219     Document Type: Article

References (64)

1. Ferencz C, Rubin JD, McCarter RJ, Brenner JI, Neill CA, Perry LW et al. Congenital heart disease: prevalence at livebirth. The Baltimore-Washington Infant Study. Am J Epidemiol 1985; 121(1) : 31-36.
2. Nora JJ. Multifactorial inheritance hypothesis for the etiology of congenital heart diseases. The genetic-environmental interaction. Circulation 1968; 38(3) : 604-617.
3. Hoffman M. How parents make their mark on genes. Science 1991; 252(5010) : 1250-1251.
4. Moraes CT, DiMauro S, Zeviani M, Lombes A, Shanske S, Miranda AF et al. Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome. N Engl J Med 1989; 320(20) : 1293-1299.
5. Health supervision for children with fragile X syndrome. American Academy of Pediatrics Committee on Genetics. Pediatrics 1996; 98(2 Pt 1) : 297-300.
6. Hagerman R. Fragile-X Syndrome. In Cassidy SB, Allanson JE, eds. Management of Genetic Syndromes. New York: Wiley-Liss; 2001; 554; 165-183.
7. Phillips MF, Harper PS. Cardiac disease in myotonic dystrophy. Cardiovasc Res 1997; 33(1) : 13-22.
8. Schmickel RD. Contiguous gene syndromes: a component of recognizable syndromes. J Pediatr 1986; 109(2) : 231-241.
9. Shaw GM, O'Malley CD, Wasserman CR, Tolarova MM, Lammer EJ. Maternal periconceptional use of multivitamins and reduced risk for conotruncal heart defects and limb deficiencies among offspring. Am J Med Genet 1995; 59(4) : 536-545.
10. Scanlon KS, Ferencz C, Loffredo CA, Wilson PD, Correa-Villasenor A, Khoury MJ et al. Preconceptional folate intake and malformations of the cardiac outflow tract. Baltimore-Washington Infant Study Group. Epidemiology 1998; 9(1) : 95-98.
11. Clark EB. Pathogenetic mechanisms of congenital cardiovascular malformations revisited. Semin Perinatol 1996; 20(6) : 465-472.
12. Goldmuntz E. Recent advances in understanding the genetic etiology of congenital heart disease. Curr Opin Pediatr 1999; 11(5) : 437-443.
13. Marino B, Digilio MC. Congenital heart disease and genetic syndromes: specific correlation between cardiac phenotype and genotype. Cardiovasc Pathol 2000; 9(6) : 303-315.
14. Strauss AW. The molecular basis of congenital cardiac disease. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 1998; 1 : 179-188.
15. Hook EB, Fabia JJ. Frequency of Down syndrome in livebirths by single-year maternal age interval: results of a Massachusetts study. Teratology 1978; 17(3) : 223-228.
16. Hook EB, Cross PK, Schreinemachers DM. Chromosomal abnormality rates at amniocentesis and in live-born infants. JAMA 1983; 249(15) : 2034-2038.
17. Korenberg JR, Chen XN, Schipper R, Sun Z, Gonsky R, Gerwehr S et al. Down syndrome phenotypes: the consequences of chromosomal imbalance. Proc Natl Acad Sci U SA 1994; 91(11) : 4997-5001.
18. Kurnit DM, Aldridge JF, Neve RL, Matthysse S. Genetics of congenital heart malformations: a stochastic model. Ann N Y Acad Sci 1985; 450 : 191-204.
19. Fuentes JJ, Pritchard MA, Planas AM, Bosch A, Ferrer I, Estivill X. A new human gene from the Down syndrome critical region encodes a proline-rich protein highly expressed in fetal brain and heart. Hum Mol Genet 1995; 4(10) : 1935-1944.
20. Cox DR, Smith SA, Epstein LB, Epstein CJ. Mouse trisomy 16 as an animal model of human trisomy 21 (Down syndrome): production of viable trisomy 16 diploid mouse chimeras. Dev Biol 1984; 101(2) : 416-424.
21. Root S, Carey JC. Survival in trisomy 18. Am J Med Genet 1994; 49(2) : 170-174.
22. Musewe NN, Alexander DJ, Teshima I, Smallhorn JF, Freedom RM. Echocardiographic evaluation of the spectrum of cardiac anomalies associated with trisomy 13 and trisomy 18. J Am Coll Cardiol 1990; 15(3) : 673-677.
23. Paul T, Reimer A, Wilken M, Miller K, Kallfelz HC. Complex cyanotic heart defect in a newborn infant with cat eye syndrome]. Monatsschr Kinderheilkd 1991; 139(4) : 228-230.
24. Freedom RM, Gerald PS. Congenital cardiac disease and the "cat eye" syndrome. Am J Dis Child 1973; 126(1) : 16-18.
25. Reynolds JF, Daniel A, Kelly TE, Gollin SM, Stephan MJ, Carey J et al. Isochromosome 12p mosaicism (Pallister mosaic aneuploidy or Pallister-Killian syndrome): report of 11 cases. Am J Med Genet 1987; 27(2) : 257-274.
26. Ranke MB, Saenger P. Turner's syndrome. Lancet 2001; 358(9278) : 309-314.
27. Mazzanti L, Cacciari E. Congenital heart disease in patients with Turner's syndrome. Italian Study Group for Turner Syndrome (ISGTS). J Pediatr 1998; 133(5) : 688-692.
28. Chu CE, Donaldson MD, Kelnar CJ, Smail PJ, Greene SA, Paterson WF et al. Possible role of imprinting in the Turner phenotype. J Med Genet 1994; 31(11) : 840-842.
29. Johnson VP, Mulder RD, Hosen R. The Wolf-Hirschhorn (4p) syndrome. Clin Genet 1976; 10(2NA-NA-760903-760909):104-112.
30. Battaglia A, Carey JC, Cederholm P, Viskochil DH, Brothman AR, Galasso C. Natural history of Wolf-Hirschhorn syndrome: experience with 15 cases. Pediatrics 1999; 103(4 Pt 1) : 830-836.
31. Burn J, Takao A, Wilson D, Cross I, Momma K, Wadey R et al. Conotruncal anomaly face syndrome is associated with a deletion within chromosome 22q11. J Med Genet 1993; 30(10) : 822-824.
32. Driscoll DA, Spinner NB, Budarf ML, McDonald-McGinn DM, Zackai EH, Goldberg RB et al. Deletions and microdeletions of 22q11.2 in velo-cardio-facial syndrome. Am J Med Genet 1992; 44(2) : 261-268.
33. Goldberg R, Motzkin B, Marion R, Scambler PJ, Shprintzen RJ. Velo-cardio-facial syndrome: a review of 120 patients. Am J Med Genet 1993; 45(3) : 313-319.
34. Thomas JA, Graham JM, Jr. Chromosomes 22q11 deletion syndrome: an update and review for the primary pediatrician. Clin Pediatr (Phila) 1997; 36(5) : 253-266.
35. Goldmuntz E, Clark BJ, Mitchell LE, Jawad AF, Cuneo BF, Reed L et al. Frequency of 22q11 deletions in patients with conotruncal defects. J Am Coll Cardiol 1998; 32(2) : 492-498.
36. Kirby ML, Gale TF, Stewart DE. Neural crest cells contribute to normal aorticopulmonary septation. Science 1983; 220(4601) : 1059-1061.
37. Yamagishi H, Garg V, Matsuoka R, Thomas T, Srivastava D. A molecular pathway revealing a genetic basis for human cardiac and craniofacial defects. Science 1999; 283(5405) : 1158-1161.
38. McDonald-McGinn DM, Kirschner R, Goldmuntz E, Sullivan K, Eicher P, Gerdes M et al. The Philadelphia story: the 22q11.2 deletion: report on 250 patients. Genet Couns 1999; 10(1) : 11-24.
39. Lashkari A, Smith AK, Graham JM, Jr. Williams-Beuren syndrome: an update and review for the primary physician. Clin Pediatr (Phila) 1999; 38(4) : 189-208.
40. Zalzstein E, Moes CA, Musewe NN, Freedom RM. Spectrum of cardiovascular anomalies in Williams-Beuren syndrome. Pediatr Cardiol 1991; 12(4) : 219-223.
41. Fryssira H, Palmer R, Hallidie-Smith KA, Taylor J, Donnai D, Reardon W. Fluorescent in situ hybridisation (FISH) for hemizygous deletion at the elastin locus in patients with isolated supra valvular aortic stenosis. J Med Genet 1997; 34(4) : 306-308.
42. Curran ME, Atkinson DL, Ewart AK, Morris CA, Leppert MF, Keating MT. The elastin gene is disrupted by a translocation associated with supravalvular aortic stenosis. Cell 1993; 73(1) : 159-68.
43. Krantz ID, Piccoli DA, Spinner NB. Alagille syndrome. J Med Genet 1997; 34(2) : 152-157.
44. Li L, Krantz ID, Deng Y, Genin A, Banta AB, Collins CC et al. Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1. Nat Genet 1997; 16(3) : 243-251.
45. Basson CT, Bachinsky DR, Lin RC, Levi T, Elkins JA, Soults J et al. Mutations in human TBX5 [corrected] cause limb and cardiac malformation in Holt-Oram syndrome. Nat Genet 1997; 15(1) : 30-35.
46. Burch M, Sharland M, Shinebourne E, Smith G, Patton M, McKenna W. Cardiologic abnormalities in Noonan syndrome: phenotypic diagnosis and echocardiographic assessment of 118 patients. J Am Coll Cardiol 1993; 22(4) : 1189-1192.
47. Marino B, Digilio MC, Toscano A, Giannotti A, Dallapiccola B. Congenital heart diseases in children with Noonan syndrome: An expanded cardiac spectrum with high prevalence of atrioventricular canal. J Pediatr 1999; 135(6) : 703-706.
48. Neri G, Zollino M, Reynolds JF. The Noonan-CFC controversy. Am J Med Genet 1991; 39(3) : 367-370.
49. Johnson JP, Golabi M, Norton ME, Rosenblatt RM, Feldman GM, Yang SP et al. Costello syndrome: phenotype, natural history, differential diagnosis, and possible cause. J Pediatr 1998; 133(3) : 441-448.
50. Hagerman RJ, Cronister A. Fragile-X syndrome : diagnosis, treatment, and research. 2nd edn. Baltimore: Johns Hopkins University Press; 1996.
51. Francke U, Furthmayr H. Genes and gene products involved in Marfan syndrome. Semin Thorac Cardiovasc Surg 1993; 5(1) : 3-10.
52. Schrijver I, Alcorn D, Franck U. Marfan Syndrome. In Cassidy SB, Allanson JE, eds. Management of genetic syndromes. New York: Wiley-Liss; 2001. p. xix, 554; 207-228.
53. De Paepe A, Devereux RB, Dietz HC, Hennekam RC, Pyeritz RE. Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet 1996; 62(4) : 417-426.
54. Mhanni AA, Cross HG, Chudley AE. Kabuki syndrome: description of dental findings in 8 patients. Clin Genet 1999; 56(2) : 154-157.
55. Digilio MC, Marino B, Toscano A, Giannotti A, Dallapiccola B. Congenital heart defects in Kabuki syndrome. Am J Med Genet 2001; 100(4) : 269-274.
56. McKusick VA. Ellis-van Creveld syndrome and the Amish. Nat Genet 2000; 24(3) : 203-204.
57. Ruiz-Perez VL, Ide SE, Strom TM, Lorenz B, Wilson D, Woods K et al. Mutations in a new gene in Ellis-van Creveld syndrome and Weyers acrodental dysostosis. Nat Genet 2000; 24(3) : 283-286.
58. Pagon RA, Graham JM Jr, Zonana J, Yong SL. Coloboma, congenital heart disease, and choanal atresia with multiple anomalies: CHARGE association. J Pediatr 1981; 99(2) : 223-227.
59. Blake KD, Davenport SL, Hall BD, Hefner MA, Pagon RA, Williams MS et al. CHARGE association: an update and review for the primary pediatrician. Clin Pediatr (Phila) 1998; 37(3) : 159-73.
60. Wyse RK, al-Mahdawi S, Burn J, Blake K. Congenital heart disease in CHARGE association. Pediatr Cardiol 1993; 14(2) : 75-81.
61. Quan L, Smith DW. The VATER association. Vertebral defects, Anal atresia, T-E fistula with esophageal atresia, Radial and Renal dysplasia: a spectrum of associated defects. J Pediatr 1973; 82(1) : 104-107.
62. Botto LD, Khoury MJ, Mastroiacovo P, Castilla EE, Moore CA, Skjaerven R et al. The spectrum of congenital anomalies of the VATER association: an international study. Am J Med Genet 1997; 71(1) : 8-15.
63. Shillingford AJ, Weiner S. Maternal issues affecting the fetus. Clin Perinatol 2001; 28(1) : 31-70.
64. Tartaglia M, Mehler EL et al. "Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome." Nat Genet 2001; 29(4) : 465-468.